Yaru Wang

机构：Shandong University of Traditional Chinese Medicine, Shandong First Medical University · ORCID：0009-0009-6088-709X

发表论文 11 篇 · 总被引 100 次 · h-index 4

代表论文

• Progress in targeting tumor-associated macrophages in cancer immunotherapy (2025 · Frontiers in Immunology · 被引 38)
• Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer (2023 · Biomedicine & Pharmacotherapy · 被引 32)
• Ferroptosis: a novel pharmacological mechanism against multiple myeloma (2025 · Frontiers in Pharmacology · 被引 12)
• American ginseng-derived extracellular vesicle-like nanoparticles (AGELNs) mitigate doxorubicin-induced cardiotoxicity by inhibiting GPX4-mediated ferroptosis (2026 · Phytomedicine · 被引 5)
• MicroRNA-218-5p accelerates malignant behaviors of breast cancer through LRIG1 (2023 · Clinics · 被引 4)
• 1MO The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) in Chinese patients (pts) with HER2-positive early breast cancer (EBC): Primary analysis of the phase III, randomised FDChina study (2022 · Annals of Oncology · 被引 4)